Position in PFE
as of Jun 30, 2026
· filed Jul 21, 2026
Position Value
$2,156,388
-$399,285 QoQ
Shares Held
89,551
-1.6% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.14%
of 13F equity value
Holder Rank
#922
of 2,821 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026LEE DANNER & BASS INC holds $56,269,792 across 8 Drug Manufacturers - General names. PFE ranks #5 (3.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
102,191 | $25,953,448 | |
| 2 | MRK |
Merck & Co., Inc.
|
89,248 | $11,468,368 | |
| 3 | AMGN |
Amgen Inc
|
21,832 | $7,905,803 | |
| 4 | ABBV |
AbbVie Inc.
|
20,843 | $5,244,932 | |
| 5 | PFE |
Pfizer Inc
This page
|
89,551 | $2,156,388 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
31,718 | $1,827,591 | |
| 7 | NVS |
Novartis AG
|
6,340 | $993,604 | |
| 8 | LLY |
ELI LILLY & Co
|
600 | $719,658 |
All Filings in PFE
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,156,388 | 89,551 | Shares | Sole | 2026-07-21 | |
| 2026-03-31 | $2,555,673 | 91,014 | Shares | Sole | 2026-04-28 | |
| 2025-12-31 | $2,332,731 | 93,684 | Shares | Sole | 2026-01-29 | |
| 2025-09-30 | $2,665,666 | 104,618 | Shares | Sole | 2025-10-29 | |
| 2025-06-30 | $2,576,299 | 106,283 | Shares | Sole | 2025-07-31 | |
| 2025-03-31 | $2,920,916 | 115,269 | Shares | Sole | 2025-04-29 | |
| 2024-12-31 | $2,964,594 | 111,745 | Shares | Sole | 2025-02-11 | |
| 2024-09-30 | $3,653,414 | 126,241 | Shares | Sole | 2024-10-30 | |
| 2024-06-30 | $3,605,530 | 128,861 | Shares | Sole | 2024-07-30 | |
| 2023-12-31 | $3,934,009 | 136,645 | Shares | Sole | 2024-02-01 | |
| 2023-09-30 | $5,203,212 | 156,865 | Shares | Sole | 2023-10-27 | |
| 2023-06-30 | $5,771,744 | 157,354 | Shares | Sole | 2023-07-31 | |
| 2023-03-31 | $6,575,491 | 161,164 | Shares | Sole | 2023-05-02 | |
| 2022-12-31 | $9,044,474 | 176,512 | Shares | Sole | 2023-02-01 | |
| 2022-09-30 | $8,175,680 | 186,830 | Shares | Sole | 2022-10-31 | |
| 2022-06-30 | $9,918,183 | 189,170 | Shares | Sole | 2022-07-25 | |
| 2022-03-31 | $10,050,886 | 194,145 | Shares | Sole | 2022-04-27 | |
| 2021-12-31 | $11,359,507 | 192,371 | Shares | Sole | 2022-01-27 | |
| 2021-09-30 | $8,362,348 | 194,428 | Shares | Sole | 2021-11-01 | |
| 2021-06-30 | $7,567,513 | 193,246 | Shares | Sole | 2021-07-27 | |
| 2021-03-31 | $6,775,915 | 187,025 | Shares | Sole | 2021-04-29 | |
| 2020-12-31 | $6,823,616 | 185,374 | Shares | Sole | 2021-02-09 | |
| 2020-09-30 | $5,980,479 | 162,956 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $5,422,777 | 165,834 | Shares | Sole | 2020-08-10 | |
| 2020-03-31 | $5,604,378 | 171,703 | Shares | Sole | 2020-05-04 | |
| No filing history on record for this holder in this stock. | ||||||